Shares of Tilray Brands, Inc. (NASDAQ:TLRY - Get Free Report) traded up 4.5% during trading on Wednesday . The company traded as high as $6.94 and last traded at $6.75. 3,075,052 shares were traded during mid-day trading, a decline of 16% from the average session volume of 3,669,190 shares. The stock had previously closed at $6.46.
Analyst Ratings Changes
TLRY has been the subject of a number of research reports. Roth Mkm upgraded shares of Tilray Brands from a "neutral" rating to a "buy" rating and set a $10.00 price objective for the company in a report on Thursday, April 2nd. TD Cowen dropped their price objective on shares of Tilray Brands from $10.00 to $7.00 and set a "buy" rating for the company in a report on Monday, March 30th. Canaccord Genuity Group initiated coverage on shares of Tilray Brands in a report on Tuesday, January 27th. They issued a "hold" rating for the company. Wall Street Zen upgraded shares of Tilray Brands from a "sell" rating to a "hold" rating in a report on Saturday, March 21st. Finally, ATB Cormark Capital Markets dropped their price objective on shares of Tilray Brands from $9.50 to $9.00 and set a "sector perform" rating for the company in a report on Thursday, April 2nd. Three equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Tilray Brands currently has a consensus rating of "Hold" and an average price target of $11.20.
Read Our Latest Report on Tilray Brands
Tilray Brands Price Performance
The firm has a market cap of $786.42 million, a price-to-earnings ratio of -0.49 and a beta of 2.00. The business's 50-day simple moving average is $7.18 and its two-hundred day simple moving average is $10.08. The company has a current ratio of 2.79, a quick ratio of 1.72 and a debt-to-equity ratio of 0.19.
Tilray Brands (NASDAQ:TLRY - Get Free Report) last released its earnings results on Wednesday, April 1st. The company reported ($0.24) earnings per share for the quarter, missing analysts' consensus estimates of ($0.14) by ($0.10). The firm had revenue of $206.73 million for the quarter, compared to analyst estimates of $201.35 million. Tilray Brands had a negative net margin of 156.51% and a negative return on equity of 3.31%. During the same period in the prior year, the company posted ($0.87) EPS. As a group, research analysts expect that Tilray Brands, Inc. will post -0.2 EPS for the current fiscal year.
Institutional Trading of Tilray Brands
Several large investors have recently modified their holdings of the stock. Tidal Investments LLC grew its position in shares of Tilray Brands by 15.0% during the 2nd quarter. Tidal Investments LLC now owns 28,971,835 shares of the company's stock worth $12,006,000 after buying an additional 3,776,410 shares during the period. Millennium Management LLC grew its position in shares of Tilray Brands by 281.0% during the 3rd quarter. Millennium Management LLC now owns 4,942,319 shares of the company's stock worth $8,550,000 after buying an additional 3,645,060 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in shares of Tilray Brands during the 3rd quarter worth approximately $5,813,000. Ausdal Financial Partners Inc. acquired a new stake in shares of Tilray Brands during the 2nd quarter worth approximately $939,000. Finally, Swiss National Bank grew its position in shares of Tilray Brands by 4.4% during the 3rd quarter. Swiss National Bank now owns 2,013,038 shares of the company's stock worth $3,483,000 after buying an additional 84,900 shares during the period. Institutional investors and hedge funds own 9.35% of the company's stock.
Tilray Brands Company Profile
(
Get Free Report)
Tilray Brands, Inc is a global cannabis-lifestyle and consumer packaged goods company engaged in the cultivation, production, distribution and sale of cannabis and cannabinoid-based products. The company develops and markets a diverse portfolio of branded products spanning medical cannabis, adult-use recreational products and wellness offerings. Through state-of-the-art cultivation facilities, research and development efforts, and quality control systems, Tilray Brands aims to deliver consistent, scalable products for a range of patient and consumer needs.
Tilray's product lineup includes cannabis flower, pre-rolls, oils and tinctures, vapes, edibles and topicals, as well as hemp-derived cannabidiol (CBD) products.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tilray Brands, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray Brands wasn't on the list.
While Tilray Brands currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for April 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.